Coldstream Capital Management Inc Amneal Pharmaceuticals, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,763 shares of AMRX stock, worth $13,293. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,763Holding current value
$13,293% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
230Shares Held
131MCall Options Held
497KPut Options Held
109K-
Vanguard Group Inc Valley Forge, PA15.8MShares$119 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$93 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$85.1 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$80.9 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$67.7 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.14B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...